Австралия - английский - Department of Health (Therapeutic Goods Administration)

abbvie pty ltd - 45895 - breast prosthesis fill tube plug kit - the fill tube plug kit is used to seal the fill tube of double lumen saline/gel breast implants following satisfactory expansion and removal of the injection port.

Европейский союз - английский - EMA (European Medicines Agency)

roche registration gmbh - trastuzumab - stomach neoplasms; breast neoplasms - antineoplastic agents - breast cancermetastatic breast cancerherceptin is indicated for the treatment of patients with her2-positive metastatic breast cancer:as monotherapy for the treatment of those patients who have received at least two chemotherapy regimens for their metastatic disease. prior chemotherapy must have included at least an anthracycline and a taxane unless patients are unsuitable for these treatments. hormone-receptor-positive patients must also have failed hormonal therapy, unless patients are unsuitable for these treatments;in combination with paclitaxel for the treatment of those patients who have not received chemotherapy for their metastatic disease and for whom an anthracycline is not suitable;in combination with docetaxel for the treatment of those patients who have not received chemotherapy for their metastatic disease;in combination with an aromatase inhibitor for the treatment of postmenopausal patients with hormone-receptor-positive metastatic breast cancer, not previously treated with trastuzumab.early breast cancerherceptin is indicated for the treatment of patients with her2-positive early breast cancer:following surgery, chemotherapy (neoadjuvant or adjuvant) and radiotherapy (if applicable);following adjuvant chemotherapy with doxorubicin and cyclophosphamide, in combination with paclitaxel or docetaxel;in combination with adjuvant chemotherapy consisting of docetaxel and carboplatin;in combination with neoadjuvant chemotherapy followed by adjuvant herceptin therapy, for locally advanced (including inflammatory) disease or tumours >2 cm in diameter.herceptin should only be used in patients with metastatic or early breast cancer whose tumours have either her2 overexpression or her2 gene amplification as determined by an accurate and validated assay.metastatic gastric cancerherceptin in combination with capecitabine or 5-fluorouracil and cisplatin is indicated for the treatment of patients with her2-positive metastatic adenocarcinoma of the stomach or gastroesophageal junction who have not received prior anticancer treatment for their metastatic disease.herceptin should only be used in patients with metastatic gastric cancer whose tumours have her2 overexpression as defined by ihc2+ and a confirmatory sish or fish result, or by an ihc3+ result. accurate and validated assay methods should be used.

Австралия - английский - Department of Health (Therapeutic Goods Administration)

j b medical supplies pty ltd t/a laborie medical technologies australia - 61734 - breast pump support kit, reusable - a collection of sterile items intended to be used in conjunction with a manual or electric breast pump (not included) to assist mothers in extracting milk from the breast for collection and/or feeding an infant. it includes various items such as funnel-like breast shields, tubing, connectors, and infant feeding bottle. this is a reusable device.

Австралия - английский - Department of Health (Therapeutic Goods Administration)

midmed pty ltd - 45136 - breast milk collection bag - to collect and store breast milk for immediate or later use.

Канада - английский - Health Canada

east-man feeds ltd. - iron (iron dextran complex) - liquid - 100mg - iron (iron dextran complex) 100mg - swine (pigs)

Соединенные Штаты - английский - NLM (National Library of Medicine)

west-ward pharmaceuticals corp - mefloquine hydrochloride (unii: 5y9l3636o3) (mefloquine - unii:tml814419r) - mefloquine hydrochloride 250 mg - treatment of acute malaria infections :  mefloquine hydrochloride tablets are indicated for the treatment of mild to moderate acute malaria caused by mefloquine-susceptible strains of p. falciparum (both chloroquine-susceptible and resistant strains) or by plasmodium vivax. there are insufficient clinical data to document the effect of mefloquine in malaria caused by p. ovale or p. malariae.   note: patients with acute p. vivax malaria, treated with mefloquine, are at high risk of relapse because mefloquine does not eliminate exoerythrocytic (hepatic phase) parasites. to avoid relapse, after initial treatment of the acute infection with mefloquine, patients should subsequently be treated with an 8-aminoquinoline derivative (e.g., primaquine). prevention of malaria :  mefloquine hydrochloride tablets are indicated for the prophylaxis of p. falciparum and p. vivax malaria infections, including prophylaxis of chloroquine-resistant strains of p. falciparum. use of mefloquine hydrochloride tablets is contraindica

Соединенные Штаты - английский - NLM (National Library of Medicine)

newton laboratories, inc. - bufo bufo cutaneous gland (unii: q59qu6n72q) (bufo bufo cutaneous gland - unii:q59qu6n72q), apis mellifera (unii: 7s82p3r43z) (apis mellifera - unii:7s82p3r43z), asterias rubens (unii: a7fyy9q742) (asterias rubens - unii:a7fyy9q742), atropa belladonna (unii: wqz3g9pf0h) (atropa belladonna - unii:wqz3g9pf0h), bryonia alba root (unii: t7j046yi2b) (bryonia alba root - unii:t7j046yi2b), oyster shell calcium carbonate, crude (unii: 2e32821g6i) (oyster shell calcium carbonate, crude - unii:2e32821g6i), matricaria - bufo bufo cutaneous gland 15 [hp_x] in 1 g - breast care - fibrocystic   formulated for symptoms associated with fibrocystic breasts, mastitis, post-partum and breast-feeding disorders and other related breast conditions. formulated for symptoms associated with fibrocystic breasts, mastitis, post-partum and breast-feeding disorders and other related breast conditions.

Великобритания - английский - MHRA (Medicines & Healthcare Products Regulatory Agency)

wfbm healthcare ltd - yeast plasmolysate - oral solution - 800microlitre/1ml

Австралия - английский - Department of Health (Therapeutic Goods Administration)

integria healthcare australia pty ltd - yeast dried -

Австралия - английский - Department of Health (Therapeutic Goods Administration)

herbs of gold pty ltd - trigonella foenum-graecum, quantity: 750 mg (equivalent: trigonella foenum-graecum, qty 3 g); cnicus benedictus, quantity: 250 mg (equivalent: cnicus benedictus, qty 1 g) - tablet, film coated - excipient ingredients: maltodextrin; povidone; microcrystalline cellulose; magnesium stearate; carnauba wax; colloidal anhydrous silica; croscarmellose sodium; crospovidone; calcium hydrogen phosphate dihydrate; hypromellose; macrogol 8000 - traditionally used in western herbal medicine to nutritive tonic ; maintain/support healthy appetite ; traditionally used in western herbal medicine to galactogogue/lactogogue/enhance/improve/promote/increase breast milk production ; maintain/support breast milk production/lactation